Blueprint Medicines Corporation
BPMC
|
|
| |
|
| Trading Volume | 14,731 |
|
|
108.38 - 43.96 |
| Market Cap Full | $ 5.7B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 1.4% | 2.8% | 2.7% | -38.7% |
| Q2 | - | 10.6% | 40.5% | -22.6% |
| Q3 | - | -13.7% | -20.5% | 30.5% |
| Q4 | - | -14.1% | 88.8% | -33.5% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.4 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -13.8 | 17.6 | 1.4 | -8.3 | 21.4 | 1.2 | 1.5 | -13.7 | - | - | - | -9.6 |
| 2023 | |||||||||||
| 6.7 | -9.4 | 6.2 | 13.5 | 10.7 | 11.8 | 4.4 | -24.5 | 0.7 | 17.2 | 18.3 | 32.5 |
| 2022 | |||||||||||
| -27.6 | -21.5 | 7.8 | -10.6 | -5.7 | -8.2 | 0.2 | 43.9 | -9.5 | -21.3 | -7.8 | -8.3 |
| 2021 | |||||||||||
| -13.8 | 1.5 | -1 | -0.9 | -5.2 | -3.7 | -0.1 | 6.2 | 11.9 | 7.8 | -14.5 | 10.6 |
| 2020 | |||||||||||
| -22.3 | -17.1 | 12.7 | 0.6 | 10.7 | 19.7 | -6.2 | 4.7 | 21 | 10.3 | 4.6 | 4.8 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -2.2 | -1.8 | -1.7 | -2.1 |
| Q2 | -2.2 | -2.7 | -1.9 | -2.3 |
| Q3 | -2.2 | -2.2 | -2 | 11.2 |
| Q4 | 0 | -2.7 | -5.4 | -1.2 |
| A | -6.54 | -9.4 | -11 | 5.6 |